Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer
Authors
Keywords
-
Journal
LABORATORY INVESTIGATION
Volume 94, Issue 12, Pages 1431-1445
Publisher
Springer Nature
Online
2014-10-06
DOI
10.1038/labinvest.2014.123
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer
- (2015) Zhongwu li et al. Oncotarget
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- In Vivo RNAi Screen for BMI1 Targets Identifies TGF-β/BMP-ER Stress Pathways as Key Regulators of Neural- and Malignant Glioma-Stem Cell Homeostasis
- (2013) Gaetano Gargiulo et al. CANCER CELL
- Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck
- (2013) Kazuaki Chikamatsu et al. CANCER SCIENCE
- BMI-1 activation is crucial in hTERT-induced epithelial–mesenchymal transition of oral epithelial cells
- (2013) Bin Qiao et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis
- (2013) Zicheng Wei et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Identification of stem cells that maintain and regenerate lingual keratinized epithelial cells
- (2013) Toshihiro Tanaka et al. NATURE CELL BIOLOGY
- Self-renewal as a therapeutic target in human colorectal cancer
- (2013) Antonija Kreso et al. NATURE MEDICINE
- Relevance of cancer initiating/stem cells in carcinogenesis and therapy resistance in oral cancer
- (2013) Niharika Sinha et al. ORAL ONCOLOGY
- The cancer stem cell hypothesis applied to oral carcinoma
- (2013) M.A. González-Moles et al. ORAL ONCOLOGY
- Inhibition of Histone Deacetylase Impacts Cancer Stem Cells and Induces Epithelial-Mesenchyme Transition of Head and Neck Cancer
- (2013) Fernanda S. Giudice et al. PLoS One
- Histone deacetylase inhibitor induction of epithelial–mesenchymal transitions via up-regulation of Snail facilitates cancer progression
- (2012) Guan-Min Jiang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Chromosome Instability Modulated by BMI1-AURKA Signaling Drives Progression in Head and Neck Cancer
- (2012) C.-H. Chou et al. CANCER RESEARCH
- Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cells
- (2012) Annette Romanski et al. CELL CYCLE
- shRNA-mediated knockdown of Bmi-1 inhibit lung adenocarcinoma cell migration and metastasis
- (2012) Xiuxiang Meng et al. LUNG CANCER
- Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells
- (2012) Dejuan Kong et al. PLoS One
- Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences
- (2012) Hifzur Rahman Siddique et al. STEM CELLS
- Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer
- (2011) Wei Liu et al. CANCER
- Functional Crosstalk between Bmi1 and MLL/Hoxa9 Axis in Establishment of Normal Hematopoietic and Leukemic Stem Cells
- (2011) Lan-Lan Smith et al. Cell Stem Cell
- Cellular senescence and tumor suppressor gene p16
- (2011) Hani Rayess et al. INTERNATIONAL JOURNAL OF CANCER
- BMI1 as a novel target for drug discovery in cancer
- (2011) Liangxian Cao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer
- (2011) Bao-Hong Guo et al. Molecular Cancer
- Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma
- (2011) Cheng Wang et al. MOLECULAR CARCINOGENESIS
- BMI1 promotes the progression of laryngeal squamous cell carcinoma
- (2011) Hui Chen et al. ORAL ONCOLOGY
- Overexpression of BMI-1 Promotes Cell Growth and Resistance to Cisplatin Treatment in Osteosarcoma
- (2011) Zhihong Wu et al. PLoS One
- Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue
- (2010) V Häyry et al. BRITISH JOURNAL OF CANCER
- Ink4a/Arf and Oncogene-Induced Senescence Prevent Tumor Progression during Alternative Colorectal Tumorigenesis
- (2010) Moritz Bennecke et al. CANCER CELL
- The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors
- (2010) Prashant V. Bommi et al. CELL CYCLE
- Bmi-1 Is a Crucial Regulator of Prostate Stem Cell Self-Renewal and Malignant Transformation
- (2010) Rita U. Lukacs et al. Cell Stem Cell
- Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
- (2010) Martin Sauvageau et al. Cell Stem Cell
- Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3
- (2010) Ji-Won Jung et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- BMI1'S maintenance of the proliferative capacity of laryngeal cancer stem cells
- (2010) Hui Chen et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT
- (2010) Francesca Bruzzese et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Eaten alive: a history of macroautophagy
- (2010) Zhifen Yang et al. NATURE CELL BIOLOGY
- Potential role of HDAC inhibitors in cancer therapy: Insights into oral squamous cell carcinoma
- (2010) A. Iglesias-Linares et al. ORAL ONCOLOGY
- The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells
- (2009) Li-Bing Song et al. JOURNAL OF CLINICAL INVESTIGATION
- The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines
- (2009) Michael B Prystowsky et al. JOURNAL OF PATHOLOGY
- Upregulation of vimentin and aberrant expression of E-cadherin/β-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome
- (2009) Lai-Kui Liu et al. MODERN PATHOLOGY
- In Brief
- (2009) NATURE REVIEWS NEUROSCIENCE
- Antitumor activity of suberoylanilide hydroxamic acid against human oral squamous cell carcinoma cell lines in vitro and in vivo
- (2009) Tatsuhito Nagumo et al. ORAL ONCOLOGY
- Recent advances in oral oncology 2008; squamous cell carcinoma imaging, treatment, prognostication and treatment outcomes
- (2009) Crispian Scully et al. ORAL ONCOLOGY
- BMI-1 Promotes Ewing Sarcoma Tumorigenicity Independent of CDKN2A Repression
- (2008) D. Douglas et al. CANCER RESEARCH
- The Polycomb Gene Product BMI1 Contributes to the Maintenance of Tumor-Initiating Side Population Cells in Hepatocellular Carcinoma
- (2008) T. Chiba et al. CANCER RESEARCH
- Recent Advances in Head and Neck Cancer
- (2008) Robert I. Haddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion
- (2008) J. S. Dovey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now